Streetbeat News

Products Services

ARRY

BLUE

CVAC

DEC

IVVD

LYFT

QURE

SFWL

TFFP

VTNR

U.S. stocks traded higher, but several companies saw their shares fall. bluebird bio announced a $150 million public offering, causing its stock to drop 14.2%. CureVac shares plummeted 35.7% after a German Federal Patent Court decision. Other stocks that moved lower include Shengfeng Development, Invivyd, Diversified Energy, Vertex Energy, uniQure, TFF Pharmaceuticals, Lyft, and Array Technologies, with various factors such as downgrades and clinical trial updates influencing their declines.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 3:19 pm

SOLUSD

Metaplex, a protocol on the Solana blockchain, has announced a new standard for immutable digital assets, which is expected to enhance trust in the assets stored on the Solana network. This announcement coincides with a 9.1% increase in SOL's price over the past week. The new standard includes Metaplex Inscriptions and Engravings, aiming to ensure on-chain and immutable digital assets within the Solana ecosystem, as opposed to relying on external services like Arweave, IPFS, and S3.

Portfolio Pulse from Khyathi Dalal

December 19, 2023 | 3:10 pm

AFRM

WMT

Affirm Holdings Inc (NASDAQ:AFRM) stock is trading higher after announcing the expansion of its services to include self-checkout at Walmart Inc (NYSE:WMT) stores. This service will be available for the holiday season at over 4,500 U.S. locations. The expansion allows Walmart shoppers to use Affirm's flexible pay-over-time options at self-checkout kiosks, online, and in Walmart apps, including Vision and Auto Centers. Affirm's research indicates a strong consumer demand for buy now, pay later options, with a significant percentage of consumers likely to delay or avoid purchases without such options. Analysts have mixed ratings on Affirm, with a consensus price target of $26.67.

Portfolio Pulse from Adam Eckert

December 19, 2023 | 3:05 pm

IFF

IFF (NYSE:IFF) is expanding its partnership with Kemira to commercialize a new portfolio of renewable polymers derived from IFF's Designed Enzymatic Biomaterials (DEB) technology. These biopolymers, made from plant sugars, will be produced at industrial scale and integrated into Chemigate Ltd's biorefinery in Finland, operational by mid-2024. The collaboration aims to supply alternatives to fossil-based synthetic polymers for various markets, including pulp, paper, packaging, and water treatment. IFF's DEB technology, initially launched for home and personal care markets, will now offer high-performance material solutions to promote a circular bioeconomy. The materials will expand IFF's AURIST™ biopolymers and Nuvolve® engineered polysaccharides product lines.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 3:03 pm

FOLD

Amicus Therapeutics (NASDAQ:FOLD) received mixed analyst ratings in the last quarter, with 2 somewhat bullish and 2 indifferent ratings. The average 12-month price target for FOLD is $17.00, with a high of $20.00 and a low of $14.00. This target has increased by 11.48% over the past month. Analysts from Morgan Stanley and JP Morgan have adjusted their price targets and ratings, reflecting their latest views on the company's performance and market conditions. Amicus Therapeutics is a biotech company focused on rare metabolic diseases, showing strong revenue growth and efficient cost management but facing challenges in debt management.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 3:01 pm

IGC

IGC Pharma, Inc. (NYSE:IGC) has received a patent in Mexico for its Alzheimer's treatment, 'Method and Composition for Treating CNS Disorder.' The company is conducting a Phase 2 trial for IGC-AD1, aimed at treating agitation in Alzheimer's patients. The patent is a key step towards potential commercialization in various jurisdictions, including the U.S. and Europe. Alzheimer's disease is a significant public health concern, with rising numbers and costs. IGC Pharma is developing multiple drug assets to address Alzheimer's-related agitation.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:29 pm

EADSY

ESYJY

easyJet Plc has confirmed an order for 157 additional A320neo Family aircraft from Airbus SE, with options for 100 more. The order includes 56 A320neo and 101 A321neo models, with deliveries scheduled between FY29 and FY34. This move aims to grow capacity, improve cost and sustainability, and replace older A320ceo aircraft. The new aircraft offer 13% to 30% better fuel efficiency and half the noise footprint. easyJet's stock (ESYJY) closed higher by 0.80% at $6.27.

Portfolio Pulse from Shivani Kumaresan

December 19, 2023 | 2:26 pm

Safe Bulkers, Inc. has agreed to acquire a new Japanese Kamsarmax class dry-bulk vessel with a capacity of 82,000 dwt, to be delivered in the first half of 2026. The financial terms of the acquisition were not disclosed. The vessel will comply with the Phase 3 Energy Efficiency Design Index for GHG emissions reduction and NOx-Tier III emissions standards. It is a sister vessel to others in Safe Bulkers' orderbook, featuring advanced energy efficiency for reduced fuel consumption.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:08 pm

PPSI

Pioneer Power Solutions, Inc. (NASDAQ:PPSI) announced receiving three new orders totaling $3.1 million for its e-Boost mobile electric charging solutions. These orders are expected to contribute significantly to the company's revenue and operating margin in 2024. The orders include two from new customers and one reorder, showcasing the adoption and versatility of the e-Boost solutions across different platforms: Pod, Mobile, and Mini. Deliveries and installations are set to begin in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:08 pm

AFRM

WMT

Affirm Holdings, Inc. (AFRM) shares have risen following the announcement of the expansion of its services to include self-checkout at Walmart stores.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:07 pm